Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-20

Clinical Trial Update: Naldebain for Pain Management of Laparoscopic Cholecystectomy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Naldebain in postoperative pain management after laparoscopic cholecystectomy (Phase 2/Phase 3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naldebain (dinalbuphine ester)

Snippet

Sponsor: E-DA Hospital | Conditions: Pain, Postoperative, Pain, Chronic | Phase 2, Phase 3 | Status: COMPLETED